Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Oral ulcers are common in SLE patients and often link to other symptoms.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.